Literature DB >> 18029336

Effectiveness of mesalamine and propolis in experimental colitis.

Ahmet Aslan1, Muhyittin Temiz, Esin Atik, Gurbuz Polat, Nuray Sahinler, Elmir Besirov, Nedim Aban, Cem Kaan Parsak.   

Abstract

This study was conducted to investigate the effects of propolis and mesalamine on experimental colitis in rats. Distal colitis was induced in rats by intracolonic instillation of 2 mL of 4% acetic acid. The animals were randomly assigned to 5 groups: group 1, control, (n=8); group 2, colitis, received no treatment (n=8); group 3, colitis+mesalamine, 2 mL once a day via an enema (n=8); group 4, colitis+propolis, 600 mg/kg once a day via intragastric lavage (n=8); and group 5, colitis+mesalamine+propolis for 1 wk (n=8). Levels of nitric oxide were statistically significantly different in comparisons between groups 1 and 2, groups 2 and 3, and groups 4 and 5. Malondialdehyde levels were significantly different when group 2 was compared with groups 3, 4, and 5. A significant difference was observed when group 3 was compared with group 4 for myeloperoxidase. Most propolis-treated rats had normal histology; mesalamine-treated and propolis+mesalamine-treated rats had inflammatory cell infiltration at rates of 50% and 33%, respectively. The investigators concluded that propolis and mesalamine are efficient independently and in combination, but that their combined effect was not observed to be additive in experimental colitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18029336     DOI: 10.1007/bf02877715

Source DB:  PubMed          Journal:  Adv Ther        ISSN: 0741-238X            Impact factor:   3.845


  9 in total

1.  5-aminosalicylic acid (5-ASA) can reduce levels of oxidative DNA damage in cells of colonic mucosa with and without fecal stream.

Authors:  Caroline Caltabiano; Felipe Rodrigues Máximo; Ana Paula Pimentel Spadari; Daniel Duarte da Conceição Miranda; Marcia Milena Pivatto Serra; Marcelo Lima Ribeiro; Carlos Augusto Real Martinez
Journal:  Dig Dis Sci       Date:  2010-11-02       Impact factor: 3.199

2.  Effectiveness of budesonide-succinate-dextran conjugate as a novel prodrug of budesonide against acetic acid-induced colitis in rats.

Authors:  Jaleh Varshosaz; Jaber Emami; Afshin Fassihi; Naser Tavakoli; Mohsen Minaiyan; Fatemeh Ahmadi; Parvin Mahzouni; Farid Dorkoosh
Journal:  Int J Colorectal Dis       Date:  2010-07-29       Impact factor: 2.571

3.  A review of the biological and pharmacological activities of mesalazine or 5-aminosalicylic acid (5-ASA): an anti-ulcer and anti-oxidant drug.

Authors:  Mohammad Beiranvand
Journal:  Inflammopharmacology       Date:  2021-08-19       Impact factor: 4.473

4.  Brazilian green propolis hydroalcoholic extract reduces colon damages caused by dextran sulfate sodium-induced colitis in mice.

Authors:  Luisa Nathália Bolda Mariano; Caroline Arruda; Lincon Bordignon Somensi; Ana Paula Michels Costa; Eduardo Gnoatto Perondi; Thaise Boeing; Marihá Mariott; Rita de Cássia Melo Vilhena de Andrade Fonseca da Silva; Priscila de Souza; Jairo Kenupp Bastos; Sérgio Faloni de Andrade; Luisa Mota da Silva
Journal:  Inflammopharmacology       Date:  2018-04-09       Impact factor: 4.473

5.  Colon delivery of budesonide using solid dispersion in dextran for the treatment and secondary prevention of ulcerative colitis in rat.

Authors:  Jaleh Varshosaz; Fatemeh Ahmadi; Jaber Emami; Naser Tavakoli; Mohsen Minaiyan; Parvin Mahzouni; Farid Dorkoosh
Journal:  Int J Prev Med       Date:  2010

Review 6.  Propolis and Its Potential to Treat Gastrointestinal Disorders.

Authors:  Luisa Mota da Silva; Priscila de Souza; Soad K Al Jaouni; Steve Harakeh; Shahram Golbabapour; Sérgio Faloni de Andrade
Journal:  Evid Based Complement Alternat Med       Date:  2018-03-15       Impact factor: 2.629

7.  Use of propolis hydroalcoholic extract to treat colitis experimentally induced in rats by 2,4,6-trinitrobenzenesulfonic Acid.

Authors:  Cely Cristina Martins Gonçalves; Luzmarina Hernandes; Ciomar Aparecida Bersani-Amado; Selma Lucy Franco; Joaquim Felipe de Souza Silva; Maria Raquel Marçal Natali
Journal:  Evid Based Complement Alternat Med       Date:  2013-09-11       Impact factor: 2.629

8.  Does propolis affect the quality of life and complications in subjects with irritable bowel syndrome (diagnosed with Rome IV criteria)? A study protocol of the randomized, double-blinded, placebo-controlled clinical trial.

Authors:  Mahsa Miryan; Pezhman Alavinejad; Mohammadreza Abbaspour; Davood Soleimani; Alireza Ostadrahimi
Journal:  Trials       Date:  2020-08-05       Impact factor: 2.279

9.  Oral administration of Korean propolis extract ameliorates DSS-induced colitis in BALB/c mice.

Authors:  Soonjae Hwang; Samnoh Hwang; Minjeong Jo; Chang Gun Lee; Ki-Jong Rhee
Journal:  Int J Med Sci       Date:  2020-07-25       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.